New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2

Background. The detrimental interaction of complex inflammatory pathways, which are chronically present in metabolic-associated steatotic liver disease (MASLD), can be dramatically exacerbated in the setting of COVID-19, contributing to the development of liver fibrosis. To date, there is no consens...

Full description

Saved in:
Bibliographic Details
Main Authors: V.I. Didenko, S.L. Melanich, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko, H.I. Bocharov
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2025-06-01
Series:Gastroenterologìa
Subjects:
Online Access:https://gastro.zaslavsky.com.ua/index.php/journal/article/view/674
Tags: Add Tag
No Tags, Be the first to tag this record!